Active substances
Paracetamol + Phenylephrine
- SFDA 1
- Health Canada 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PANADOL SINUS RELIEF PE CAPLET | 500,5 mg,mg | Tablet · Oral use | 24 Blister | SAR 10.70 | Generic · OTC | GLAXO EXPORT LIMITED | Withdrawn by MAH · Not Marketed |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BENYLIN EXTRA STRENGTH COLD & SINUS DAY | 02273462 | 500 MG; 5 MG | TABLET · ORAL | KENVUE CANADA INC. |
| DAYQUIL SINUS LIQUICAPS | 02273829 | 5 MG; 325 MG | CAPSULE · ORAL | PROCTER & GAMBLE INC |
| EXTRA STRENGTH TYLENOL SINUS DAYTIME | 02276003 | 5 MG; 500 MG | TABLET · ORAL | KENVUE CANADA INC. |
| NEOCITRAN EXTRA STRENGTH COLD & CONGESTION | 00843792 | 650 MG / SACHET; 10 MG / SACHET | POWDER FOR SOLUTION · ORAL | HALEON CANADA ULC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.